Reversing modifications in diseased heart muscle cell struts called microtubules (MT) can lessen the stiffness and improve the beating strength of these cells isolated from transplant patients with heart failure.
List view / Grid view
Hypertrophic cardiomyopathy (HCM)
"Well thought through and brilliantly executed" study shows different DNA-repair mechanism in embryos compared to iPSCs
31 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Using advanced stem cell technology, scientists from the Icahn School of Medicine at Mount Sinai have created a model of a heart condition called hypertrophic cardiomyopathy (HCM), an excessive thickening of the heart that is associated with a number of rare and common illnesses, some of which have a strong…
Sanofi and MyoKardia announce groundbreaking collaboration to develop targeted therapies for patients with genetic heart disease
19 September 2014 | By Sanofi
Sanofi and MyoKardia, Inc. announced a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most common forms of heart muscle disease...